NUVB

NUVB

USD

Nuvation Bio Inc. Class A Common Stock

$4.830-0.320 (-6.214%)

即時價格

Healthcare
生物科技
美國

價格圖表

Loading Chart...

關鍵指標

市場指標
公司基本面
交易統計

市場指標

開盤

$5.150

最高

$5.190

最低

$3.920

交易量

6.20M

公司基本面

市值

1.7B

行業

生物科技

國家

United States

交易統計

平均交易量

7.11M

交易所

NYQ

貨幣

USD

52週範圍

最低 $1.54當前 $4.830最高 $5.55

相關新聞

Analyst Upgrades

RBC Capital Maintains Outperform on Nuvation Bio, Raises Price Target to $8

RBC Capital analyst Leonid Timashev maintains Nuvation Bio with a Outperform and raises the price target from $7 to $8.

查看更多
RBC Capital Maintains Outperform on Nuvation Bio, Raises Price Target to $8
BusinessWire

Nuvation Bio Reports Third Quarter 2025 Financial Results and Provides Business Update

Successfully started 204 patients on IBTROZI™ (taletrectinib) in the third quarter of 2025 Updated data continue to show IBTROZI's unprecedented durability in TKI-naïve, advanced ROS1-positive (ROS1+) non-small

查看更多
Nuvation Bio Reports Third Quarter 2025 Financial Results and Provides Business Update
BusinessWire

Nuvation Bio to Participate in Upcoming Investor Conferences

Nuvation Bio Inc. (NYSE:NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced that David Hung, M.D., Founder, President, and Chief Executive Officer of

查看更多
Nuvation Bio to Participate in Upcoming Investor Conferences